Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

Summary

The goal of the present study is to evaluate ("screen") a large number (12) of different dual therapies of perampanel + another AED ("PMP+") for a large, 75-100% seizure frequency reduction. The design of the study will differ from usual AED studies. The study will be (i) open label, with (ii) a small n per group, n=6, with (iii) outcome measures a 'blockbuster effect': (a) ≥75 seizure frequency reduction; and (b) seizure freedom.

Timeline

Start

2015-11

Primary completion

2017-07

Completion

2017-07

Drugs

Indications